164 related articles for article (PubMed ID: 34905776)
1. Management of bladder cancer in older patients.
Hatakeyama S; Narita S; Okita K; Narita T; Iwamura H; Fujita N; Inokuchi J; Matsui Y; Kitamura H; Ohyama C
Jpn J Clin Oncol; 2022 Mar; 52(3):203-213. PubMed ID: 34905776
[TBL] [Abstract][Full Text] [Related]
2. Impairment and Longitudinal Recovery of Older Adults Treated with Radical Cystectomy for Muscle Invasive Bladder Cancer.
Osterman CK; Deal AM; McCloskey H; Nyrop KA; Bjurlin MA; Tan HJ; Nielsen ME; Milowsky MI; Muss HB; Smith AB
J Urol; 2021 Jan; 205(1):94-99. PubMed ID: 32716672
[TBL] [Abstract][Full Text] [Related]
3. Management of muscle-invasive bladder cancer in the elderly.
Rose TL; Milowsky MI
Curr Opin Urol; 2015 Sep; 25(5):459-67. PubMed ID: 26075567
[TBL] [Abstract][Full Text] [Related]
4. Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer.
Ballas L; Singh P; Lerner SP
Urol Oncol; 2023 Jan; 41(1):35-38. PubMed ID: 33153882
[TBL] [Abstract][Full Text] [Related]
5. Management of bladder cancer in older patients: Position paper of a SIOG Task Force.
Mottet N; Ribal MJ; Boyle H; De Santis M; Caillet P; Choudhury A; Garg T; Nielsen M; Wüthrich P; Gust KM; Shariat SF; Gakis G
J Geriatr Oncol; 2020 Sep; 11(7):1043-1053. PubMed ID: 32057720
[TBL] [Abstract][Full Text] [Related]
6. Myths About Bladder Preservation in Muscle-Invasive Bladder Cancer.
Elumalai T; Joseph N; Choudhury A
Semin Radiat Oncol; 2023 Jan; 33(1):56-61. PubMed ID: 36517194
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer.
Tanaka H; Fukushima H; Kijima T; Nakamura Y; Yajima S; Uehara S; Yoshida S; Yokoyama M; Ishioka J; Matsuoka Y; Saito K; Fujii Y
Int J Urol; 2020 Mar; 27(3):236-243. PubMed ID: 31957164
[TBL] [Abstract][Full Text] [Related]
8. Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.
Johnson SB; Yu JB
Curr Oncol Rep; 2018 Jun; 20(9):66. PubMed ID: 29959582
[TBL] [Abstract][Full Text] [Related]
9. Radical radiotherapy in older patients with muscle invasive bladder cancer.
Wujanto C; Tey J; Chia D; Ho F; Ooi KH; Wong AS; Soon YY; Lim K
J Geriatr Oncol; 2019 Mar; 10(2):292-297. PubMed ID: 30630748
[TBL] [Abstract][Full Text] [Related]
10. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.
Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W
Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684
[TBL] [Abstract][Full Text] [Related]
11. Frailty as a prognostic indicator in the radical cystectomy population: a review.
Parikh N; Sharma P
Int Urol Nephrol; 2019 Aug; 51(8):1281-1290. PubMed ID: 31175538
[TBL] [Abstract][Full Text] [Related]
12. Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer: a qualitative study exploring patient priorities and counselling needs when making a treatment choice.
Verghote F; Van Praet C; Berquin C; Lumen N; Decaestecker K; Vanneste B; Rammant E; Fonteyne V
BMC Cancer; 2024 Jan; 24(1):160. PubMed ID: 38297192
[TBL] [Abstract][Full Text] [Related]
13. Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review.
Koga F; Kihara K
Int J Urol; 2012 May; 19(5):388-401. PubMed ID: 22409269
[TBL] [Abstract][Full Text] [Related]
14. Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review.
Fonteyne V; Ost P; Bellmunt J; Droz JP; Mongiat-Artus P; Inman B; Paillaud E; Saad F; Ploussard G
Eur Urol; 2018 Jan; 73(1):40-50. PubMed ID: 28478043
[TBL] [Abstract][Full Text] [Related]
15. Treatment Options and Outcomes in Nonmetastatic Muscle Invasive Bladder Cancer.
Ghandour R; Singla N; Lotan Y
Trends Cancer; 2019 Jul; 5(7):426-439. PubMed ID: 31311657
[TBL] [Abstract][Full Text] [Related]
16. Organ-conserving approaches to muscle-invasive bladder cancer: future alternatives to radical cystectomy.
Zietman AL; Shipley WU; Kaufman DS
Ann Med; 2000 Feb; 32(1):34-42. PubMed ID: 10711576
[TBL] [Abstract][Full Text] [Related]
17. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
[TBL] [Abstract][Full Text] [Related]
18. Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy.
Smith ZL; Christodouleas JP; Keefe SM; Malkowicz SB; Guzzo TJ
BJU Int; 2013 Jul; 112(1):13-25. PubMed ID: 23356411
[TBL] [Abstract][Full Text] [Related]
19. Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions.
Jiang DM; Chung P; Kulkarni GS; Sridhar SS
Curr Oncol Rep; 2020 Feb; 22(2):14. PubMed ID: 32008105
[TBL] [Abstract][Full Text] [Related]
20. Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers.
El-Taji OM; Alam S; Hussain SA
Curr Treat Options Oncol; 2016 Mar; 17(3):15. PubMed ID: 26942590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
